Semaglutide Tied to Fewer Asthma, COPD Exacerbations
The diabetes and weight loss injection semaglutide was associated with fewer asthma attacks and COPD exacerbations, according to ERS 2026 research.
Tag: GLP-1 agonists
Semaglutide Tied to Fewer Asthma, COPD Exacerbations
The diabetes and weight loss injection semaglutide was associated with fewer asthma attacks and COPD exacerbations, according to ERS 2026 research.
Read More
GLP-1s Tied to Lower Risk of Substance Use Disorders
A study of 142,000 patients suggests GLP-1 medications may influence brain pathways involved in cravings for nicotine, opioids, and alcohol.
Read More
Certain Patients Benefit Most from GLP-1 for Sleep Apnea, Obesity
A subgroup of patients using the GLP-1 tirzepatide experience nearly twice the improvement in sleep apnea severity compared to other participants.
Read More
GLP-1s Tied to Reduced Asthma Exacerbation in Obese Patients
GLP-1 initiation is associated with a 14.6% reduced risk of asthma exacerbation for overweight patients, 12.2% for obese patients and 13.3% for morbidly obese patients.
Read More
GLP-1 Agonists May Reduce Asthma Symptoms
Researchers say they found compelling evidence that GLP-1 agonists improved asthma symptoms.
Read More